Skip to content
Arvinas logo

Arvinas Alternatives & Competitors

12 companies similar to Arvinas — Leading the way in targeted protein degradation therapeutics

Companies similar to Arvinas

Avilar Therapeutics logo — alternative to Arvinas

Avilar Therapeutics

Pioneering the discovery and development of extracellular protein degraders.

Kangpu Biopharmaceuticals, Ltd. logo — alternative to Arvinas
Precigen logo — alternative to Arvinas

Precigen

Precigen (Nasdaq: PGEN) is a biopharmaceutical company advancing the next generation of ge...

Captor Therapeutics SA logo — alternative to Arvinas

Captor Therapeutics SA

Captor Therapeutics aims to treat cancer, infections, and diseases by targeting the diffic...

Rival Readout

Competing with Arvinas? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Orum Therapeutics logo — alternative to Arvinas

Orum Therapeutics

A public biotechnology company pioneering a novel class of protein degraders.

Relay Therapeutics logo — alternative to Arvinas

Relay Therapeutics

Integrating leading-edge computational and experimental science to transform human health....

Forma Therapeutics logo — alternative to Arvinas

Forma Therapeutics

Dedicated to transforming the lives of patients with rare hematologic diseases and cancers...

Cullgen Inc. logo — alternative to Arvinas

Cullgen Inc.

Powering protein degradation for tomorrow's medicines

Lisata Therapeutics, Inc. logo — alternative to Arvinas

Lisata Therapeutics, Inc.

Targeted Therapy Delivered

HAVAH Therapeutics logo — alternative to Arvinas

HAVAH Therapeutics

Developing prevention and early treatment options for hormonally driven breast cancer and...

Monte Rosa Therapeutics logo — alternative to Arvinas

Monte Rosa Therapeutics

Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly select...

Wren Therapeutics logo — alternative to Arvinas

Wren Therapeutics

Stopping the wave of neurodegeneration at its source

About Arvinas

Arvinas is a clinical-stage biopharmaceutical company founded in 2013 and headquartered in the United States. The company is committed to developing targeted protein degradation therapeutics with the aim of improving the lives of patients suffering from debilitating and life-threatening diseases. Their proprietary PROT...

Business keywords

Biopharmaceutical, Protein Degradation, Therapeutics, Clinical-stage, Disease Treatment, PROTAC® Discovery Engine Platform, Proteolysis Targeting Chimeras, Metastatic Castrate-resistant Prostate Cancer, Locally Advanced Breast Cancer, Metastatic ER+/HER2- Breast Cancer, Drug Discovery, Autoimmune Diseases, Rare Diseases, Cancer Therapy, Preclinical Pipeline

Frequently Asked Questions

Companies similar to Arvinas include Avilar Therapeutics, Kangpu Biopharmaceuticals, Ltd., Precigen, Captor Therapeutics SA, Orum Therapeutics. They work in Biotechnology and Pharmaceutical and share Arvinas's focus on drug discovery, biopharmaceutical and autoimmune diseases.
Bounce Watch lists 12 companies that share Arvinas's industries and are closest to it in business tags, services, target customers, business model and size.
Arvinas is a clinical-stage biopharmaceutical company founded in 2013 and headquartered in the United States. The company is committed to developing targeted protein degradation therapeutics with the aim of improving the lives of patients suffering from debilitating and life-threatening diseases. Their proprietary PROT...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Arvinas: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Arvinas on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout